Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
US6713508B2 · kind B2 · utility
17Cited by
11References
48Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 29, 2001 |
| Grant date | Mar 30, 2004 |
| Priority date | — |
| Expiry date | Oct 29, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A class of benzopyrancarboxylic acid derivatives comprises compounds that are potent agonists of PPAR alpha and/or gamma, and are therefore useful in the treatment, control or prevention of non-insulin dependent diabetes mellitus (NIDDM), hyperglycemia, dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, atherosclerosis, obesity, vascular restenosis, inflammation, and other PPAR alpha and/or gamma mediated diseases, disorders and conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.